141 related articles for article (PubMed ID: 36638899)
1. Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines.
Dahabiyeh LA; Hudaib F; Hourani W; Darwish W; Abu-Irmaileh B; Deb PK; Venugopala KN; Mohanlall V; Chandrashekharappa S; Abu-Dahab R; Semreen MH; Bustanji Y
Eur J Pharm Sci; 2023 Mar; 182():106378. PubMed ID: 36638899
[TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines.
Dahabiyeh LA; Hourani W; Darwish W; Hudaib F; Abu-Irmaileh B; Deb PK; Venugopala KN; Mohanlall V; Abu-Dahab R; Semreen MH; Bustanji Y
Sci Rep; 2022 Dec; 12(1):21599. PubMed ID: 36517571
[TBL] [Abstract][Full Text] [Related]
3. Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
Fan X; Rao J; Zhang Z; Li D; Cui W; Zhang J; Wang H; Tou F; Zheng Z; Shen Q
Cell Physiol Biochem; 2018; 46(4):1317-1330. PubMed ID: 29689551
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the metabolic profile and anti-colorectal cancer mechanism of Capilliposide A using ultra performance liquid chromatography mass spectrometry combined with non-targeted metabolomics studies.
Li W; Zhang X; Feng Y; Han H; Cai J; Zhao H; Li S; Tian J; Zhu W
J Pharm Biomed Anal; 2023 Sep; 234():115548. PubMed ID: 37390605
[TBL] [Abstract][Full Text] [Related]
6. LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in
Li X; Chung ACK; Li S; Wu L; Xu J; Yu J; Wong C; Cai Z
Oncotarget; 2017 Nov; 8(60):101333-101344. PubMed ID: 29254168
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Apoptotic-Induced Biochemical Mechanism of Traditional Thai Herb (Kerra™) Extract in HCT116 Cells Using a Label-Free Proteomics Approach.
Siriwaseree J; Yingchutrakul Y; Samutrtai P; Aonbangkhen C; Srathong P; Krobthong S; Choowongkomon K
Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629666
[No Abstract] [Full Text] [Related]
8. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
9. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and Apoptotic Activity of Chamaecyparis obtusa Leaf Extract against the HCT116 Human Colorectal Cancer Cell Line and Investigation of the Bioactive Compound by Gas Chromatography-Mass Spectrometry-Based Metabolomics.
Kim HY; Lee SG; Oh TJ; Lim SR; Kim SH; Lee HJ; Kim YS; Choi HK
Molecules; 2015 Oct; 20(10):18066-82. PubMed ID: 26445036
[TBL] [Abstract][Full Text] [Related]
11. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
[TBL] [Abstract][Full Text] [Related]
12. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
13. Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
Ayoup MS; Abu-Serie MM; Awad LF; Teleb M; Ragab HM; Amer A
Eur J Med Chem; 2021 Oct; 222():113558. PubMed ID: 34116327
[TBL] [Abstract][Full Text] [Related]
14. Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways.
Zheng Z; Xu L; Zhang S; Li W; Tou F; He Q; Rao J; Shen Q
Oncotarget; 2017 Jul; 8(29):47619-47631. PubMed ID: 28496003
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2.
Li B; Liu X; Wu G; Liu J; Cai S; Wang F; Yang C; Liu J
Bioengineered; 2021 Dec; 12(2):9507-9519. PubMed ID: 34699325
[TBL] [Abstract][Full Text] [Related]
16. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer evaluations of novel 1H-imidazole [4,5-f][1,10] phenanthroline derivative for the treatment of colorectal cancer.
Hu S; Ma W; Wang J; Ma Y; Zhou Z; Zhang R; Du K; Zhang H; Sun M; Jiang X; Tu H; Tang X; Yao X; Chen P
Eur J Pharmacol; 2022 Aug; 928():175120. PubMed ID: 35753402
[TBL] [Abstract][Full Text] [Related]
18. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
19. Synthetic derivatives of natural cinnamic acids as potential anti-colorectal cancer agents.
Falbo F; Gemma S; Koch A; Mazzotta S; Carullo G; Ramunno A; Butini S; Schneider-Stock R; Campiani G; Aiello F
Chem Biol Drug Des; 2024 Jan; 103(1):e14415. PubMed ID: 38230797
[TBL] [Abstract][Full Text] [Related]
20. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
